Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.

An Exploratory Clinical Trial to Evaluate the Safety and Efficacy of Sacral Nerve Stimulation in Patients

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Although the incidence of inflammatory bowel disease is stable in North American and European countries, the incidence of inflammatory bowel disease is increasing in newly industrialized countries, especially in China. The treatment drugs for ulcerative colitis include 5-aminosalicylic acid (5-ASA), glucocorticoids, immunosuppressants, and biological agents. The aim of this exploratory Clinical Trial is to evaluate the safety and efficacy of sacral nerve stimulation in patients with ulcerative colitis.

Who May Be Eligible (Plain English)

Who May Qualify: - age ≥18 years - ulcerative colitis diagnosed for at least 3 mouths. - Mayo score 6-12, Mayo endoscopic score 2-3 points - resistant to medical treatment Who Should NOT Join This Trial: - Treatment-naive ulcerative colitis (no previous treatment) - Acute severe ulcerative colitis - Currently taking any biologicals - Previous surgical treatment or severe colitis at imminent risk of surgery - infective colitis - Other systemic diseases - Pregnancy and lactation Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * age ≥18 years * ulcerative colitis diagnosed for at least 3 mouths. * Mayo score 6-12, Mayo endoscopic score 2-3 points * resistant to medical treatment Exclusion Criteria: * Treatment-naive ulcerative colitis (no previous treatment) * Acute severe ulcerative colitis * Currently taking any biologicals * Previous surgical treatment or severe colitis at imminent risk of surgery * infective colitis * Other systemic diseases * Pregnancy and lactation

Treatments Being Tested

DEVICE

G132 system, Beijing PINS Medical Co., China

Neuromodulation was performed according to the usual protocol

Locations (1)

Xijing Hospital
Xi'an, Shaanxi, China